Update

Summary by AI BETAClose X

Axis Bank Limited has received a Final Order from the Securities and Exchange Board of India (SEBI) concerning a Show Cause Notice issued on October 25, 2024, related to the purchase of shares in Max Life Insurance Company Limited. The Ld. Whole Time Member of SEBI has disposed of all proceedings against Axis Bank and its subsidiaries, Axis Securities Limited and Axis Capital Limited, without issuing any directions or imposing any penalties.

Disclaimer*

Axis Bank Limited
25 August 2026
 

AXIS/CO/CS/358/2026-27

 

August 25, 2026

 

National Stock Exchange of India Limited

Exchange Plaza,

Plot No. C/1, "G" Block

Bandra-Kurla Complex

Bandra (E), Mumbai - 400 051

 

NSE Symbol: AXISBANK

BSE Limited

P. J. Towers,

Dalal Street

Fort, Mumbai - 400 001

 

 

BSE Scrip Code: 532215

 

Dear Sir/Madam,

 

Sub.: Further disclosure in relation to purchase of shares of Max Life Insurance Company Limited

 

We refer to our earlier disclosure letter dated October 26, 2024 in relation to the Show Cause Notice ("SCN") received by Axis Bank Limited ("Axis Bank"), and its subsidiaries, Axis Securities Limited ("ASL") and Axis Capital Limited ("ACL"), through email from the Securities and Exchange Board of India ("SEBI") on October 25, 2024.

 

We now wish to inform that the Ld. Whole Time Member of SEBI has issued a Final Order No: WTM/AS/CFID/CFID-CORD/32677/2026-27 dated August 24, 2026 disposing off all proceedings against inter alia Axis Bank, ASL and ACL without issuance of any direction or imposition of any penalty.

 

We kindly request you to take note of the above on record.

http://www.rns-pdf.londonstockexchange.com/rns/1104S_1-2026-8-25.pdf

 

Thanking you,

 

With warm regards,

For Axis Bank Limited

 

 

Sandeep Poddar

Company Secretary

 

Encl.: as above

 

CC: London Stock Exchange

        Singapore Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100